Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

HLS Therapeutics Inc T.HLS

Alternate Symbol(s):  HLTRF

HLS Therapeutics Inc. is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the central nervous system and cardiovascular therapeutic areas. Its products include Clozaril, CSAN Pronto, MyCare Psychiatry and Vascepa. Its Clozaril is an atypical antipsychotic indicated for the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. The Vascepa (icosapent ethyl capsules) is a single-molecule prescription product in use to reduce the risk of cardiovascular events.


TSX:HLS - Post by User

Bullboard Posts
Comment by Aspertheoldmanon Mar 14, 2012 9:56pm
184 Views
Post# 19671765

RE: RE: RE: RE: Blair selling

RE: RE: RE: RE: Blair selling

No

Blair had 4,272,463 shares of which 4,052,463 are held directly by Renegade Capital Corp with the balance being in his RRSP.

He now has 4,000,000 shares

Scotia Merchant is completely independant of Renegade

A few weeks ago I wrote this about Scotia's selling:

 

        "  Scotia Merchant Capital (100% owned by Bank of Nova Scotia) has a long history of selling its holding of AM shares.

5 years ago they had about 9 millions shrs (40% of the company).

In november 2007 they did a secondary offering of 3 millions of their holding.

In july 2010, they sold 1.5 million shrs pursuant to the 'substantial issuer bid' under which AM offered to repurchase up to $5 million in value of its outstanding common shares.

At the beginning of 2012, they had almost 4,000,000 shares

They now have 3,408,000 shares.

As long as this large block is hanging out, I doubt AM will reach $5.00 this year as some posters are dreaming of.

The best would be for Scotia to do a secondary offering as they did in 2007 or to enter into a private agreement with another institution.

The fact that they have not done it might indicate they don't intend to sell their block in its entirety. "

 

Update; Scotia has now 2,574,062 shares.

 
Bullboard Posts